Cargando…

Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma

PURPOSE: Thyroid nodules are a kind of common endocrine system disease, with approximately 5% of them developing into malignant lesions, the most common of which belong to differentiated thyroid carcinoma (DTC). Accurate differential diagnosis using reliable methods and targeted treatment of benign...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Nan, Jiao, Benzheng, Zhang, Laney, Li, Jialong, Li, Yungeng, Lin, Chenghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339774/
https://www.ncbi.nlm.nih.gov/pubmed/37435919
http://dx.doi.org/10.1080/07853890.2023.2232372
_version_ 1785071920667951104
author Jiang, Nan
Jiao, Benzheng
Zhang, Laney
Li, Jialong
Li, Yungeng
Lin, Chenghe
author_facet Jiang, Nan
Jiao, Benzheng
Zhang, Laney
Li, Jialong
Li, Yungeng
Lin, Chenghe
author_sort Jiang, Nan
collection PubMed
description PURPOSE: Thyroid nodules are a kind of common endocrine system disease, with approximately 5% of them developing into malignant lesions, the most common of which belong to differentiated thyroid carcinoma (DTC). Accurate differential diagnosis using reliable methods and targeted treatment of benign and malignant thyroid nodules are of great significance to improve patient outcomes. This study mainly investigates the diagnostic value of thyroglobulin (Tg) and anti-thyroglobulin antibody (anti-TgAb) combined with emission computed tomography (ECT) in the adjuvant diagnosis DTC. METHODS: All the data of 387 histopathologically diagnosed DTC patients (observation group) and 151 patients with nodular goiter (control group) admitted between June 2019 and June 2021 were collected and retrospectively analyzed. Serum Tg and anti-TgAb levels were detected in all subjects. In addition, all patients in the observation group underwent thyroid ECT, and the results were compared with the pathological findings. The receiver operating characteristic (ROC) curve was drawn to analyze the diagnostic performance of Tg, TgAb and thyroid ECT, either alone or in combination, in patients with thyroid cancer (TC). RESULTS: The consistency test showed that Tg (Kappa-value = 0.370) and anti-TgAb (Kappa-value = 0.393) had generally consistent efficiency with pathological findings in the diagnosis of DTC; ECT (Kappa-value = 0.625) and the combined diagnosis of the three (Kappa-value = 0.757) showed higher consistency than the pathological diagnosis, of which the combined diagnosis contributed to an even higher consistency. The combined diagnosis of Tg, anti-TgAb, and thyroid ECT outperformed either of these alone in DTC diagnosis, with a sensitivity of 91.5%, a specificity of 86.1%, and an accuracy of 90%. CONCLUSIONS: The combination of Tg. anti-TgAb, and RNI can effectively improve the diagnostic accuracy of DTC and reduce the missed diagnosis rate, which has important reference significance for clinical diagnosis and treatment of TC.
format Online
Article
Text
id pubmed-10339774
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-103397742023-07-14 Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma Jiang, Nan Jiao, Benzheng Zhang, Laney Li, Jialong Li, Yungeng Lin, Chenghe Ann Med Oncology PURPOSE: Thyroid nodules are a kind of common endocrine system disease, with approximately 5% of them developing into malignant lesions, the most common of which belong to differentiated thyroid carcinoma (DTC). Accurate differential diagnosis using reliable methods and targeted treatment of benign and malignant thyroid nodules are of great significance to improve patient outcomes. This study mainly investigates the diagnostic value of thyroglobulin (Tg) and anti-thyroglobulin antibody (anti-TgAb) combined with emission computed tomography (ECT) in the adjuvant diagnosis DTC. METHODS: All the data of 387 histopathologically diagnosed DTC patients (observation group) and 151 patients with nodular goiter (control group) admitted between June 2019 and June 2021 were collected and retrospectively analyzed. Serum Tg and anti-TgAb levels were detected in all subjects. In addition, all patients in the observation group underwent thyroid ECT, and the results were compared with the pathological findings. The receiver operating characteristic (ROC) curve was drawn to analyze the diagnostic performance of Tg, TgAb and thyroid ECT, either alone or in combination, in patients with thyroid cancer (TC). RESULTS: The consistency test showed that Tg (Kappa-value = 0.370) and anti-TgAb (Kappa-value = 0.393) had generally consistent efficiency with pathological findings in the diagnosis of DTC; ECT (Kappa-value = 0.625) and the combined diagnosis of the three (Kappa-value = 0.757) showed higher consistency than the pathological diagnosis, of which the combined diagnosis contributed to an even higher consistency. The combined diagnosis of Tg, anti-TgAb, and thyroid ECT outperformed either of these alone in DTC diagnosis, with a sensitivity of 91.5%, a specificity of 86.1%, and an accuracy of 90%. CONCLUSIONS: The combination of Tg. anti-TgAb, and RNI can effectively improve the diagnostic accuracy of DTC and reduce the missed diagnosis rate, which has important reference significance for clinical diagnosis and treatment of TC. Taylor & Francis 2023-07-12 /pmc/articles/PMC10339774/ /pubmed/37435919 http://dx.doi.org/10.1080/07853890.2023.2232372 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
spellingShingle Oncology
Jiang, Nan
Jiao, Benzheng
Zhang, Laney
Li, Jialong
Li, Yungeng
Lin, Chenghe
Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma
title Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma
title_full Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma
title_fullStr Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma
title_full_unstemmed Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma
title_short Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma
title_sort application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339774/
https://www.ncbi.nlm.nih.gov/pubmed/37435919
http://dx.doi.org/10.1080/07853890.2023.2232372
work_keys_str_mv AT jiangnan applicationofthyroglobulinandantithyroglobulinantibodycombinedwithemissioncomputedtomographyintheadjuvantdiagnosisofdifferentiatedthyroidcarcinoma
AT jiaobenzheng applicationofthyroglobulinandantithyroglobulinantibodycombinedwithemissioncomputedtomographyintheadjuvantdiagnosisofdifferentiatedthyroidcarcinoma
AT zhanglaney applicationofthyroglobulinandantithyroglobulinantibodycombinedwithemissioncomputedtomographyintheadjuvantdiagnosisofdifferentiatedthyroidcarcinoma
AT lijialong applicationofthyroglobulinandantithyroglobulinantibodycombinedwithemissioncomputedtomographyintheadjuvantdiagnosisofdifferentiatedthyroidcarcinoma
AT liyungeng applicationofthyroglobulinandantithyroglobulinantibodycombinedwithemissioncomputedtomographyintheadjuvantdiagnosisofdifferentiatedthyroidcarcinoma
AT linchenghe applicationofthyroglobulinandantithyroglobulinantibodycombinedwithemissioncomputedtomographyintheadjuvantdiagnosisofdifferentiatedthyroidcarcinoma